biopharmacy

基本解釋

OBJECTIVE:To discuss the developmental environments suitable for Chinese biopharmacy.
前言：目的：探討適合我國生物醫(yī)藥的發(fā)展環(huán)境。
It also presents the strategies , crucial regions of industrialization development and researches prospects for our countries' marine biopharmacy.
提出我國海洋生物制藥的戰(zhàn)略決策，產(chǎn)業(yè)化發(fā)展的重點(diǎn)領(lǐng)域及研究的展望。
In the field of functional proteomics, the human disease proteomics shows great potential in the discovery of new molecular targets and biomarkers for medicine and biopharmacy.
其中，在功能蛋白質(zhì)組領(lǐng)域內(nèi)，疾病蛋白質(zhì)組學(xué)在醫(yī)學(xué)和生物制藥方面具有發(fā)現(xiàn)新分子藥靶、生物標(biāo)志物的巨大的潛力。

生物制藥
Our country regards the biopharmacy industry as the emphasis and strategic target of the scientific technology development.
我國已明確地將生物制藥產(chǎn)業(yè)作為21世紀(jì)科技發(fā)展的重點(diǎn)和戰(zhàn)略目標(biāo)。
醫(yī)藥科學(xué)
生物藥劑學(xué)
Its fundamental analysis method has penetrated into biopharmacy, medicinal chemistry, clinical treatment and promote them at the same time.
其基本分析方法已經(jīng)滲透到生物藥劑學(xué)，藥物化學(xué)，臨床治療學(xué)等多種相關(guān)學(xué)科中并推動(dòng)著這些學(xué)科蓬勃發(fā)展。